Screener
Arcosa ACA Increase (decrease) in advance billings
Increase (decrease) in advance billings at other companies
Other financials
Where this comes from
Reported directly by Arcosa in its filing.
Tagged under the XBRL concept aca:IncreaseDecreaseInAdvanceBillings.
The source filing: Arcosa’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 4:23 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001739445-26-000126
| Line item | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|
| (Increase) decrease in inventories | (22.6) | (37.1) |
| (Increase) decrease in other current assets | (5.8) | 13.5 |
| Increase (decrease) in accounts payable | 9.1 | 63.8 |
| Increase (decrease) in advance billings | 3.5 | (63.8) |
| Increase (decrease) in accrued liabilities | (10.4) | (9.5) |
| Net cash provided by operating activities - continuing operations | 33.4 | 16.9 |
| Net cash provided by operating activities - discontinued operations | 27.3 | 43.6 |
| Net cash provided by operating activities | 60.7 | 60.5 |
Item 1. Financial Statements
FAQ
- What is Arcosa's increase (decrease) in advance billings?
- Arcosa (ACA) reported increase (decrease) in advance billings of $2.1M in Q2 2026.
- How has Arcosa's increase (decrease) in advance billings changed year-over-year?
- Arcosa's increase (decrease) in advance billings increased by 110.6% year-over-year, from -$19.9M to $2.1M.
- What is the long-term trend for Arcosa's increase (decrease) in advance billings?
- Over 2 years (2021 to 2024), Arcosa's increase (decrease) in advance billings has grown at a 59.7% compound annual growth rate (CAGR), from -$26.2M to $66.8M.
- What does increase (decrease) in advance billings mean?
- Increase (decrease) in advance billings as reported by Arcosa, Inc. Common Stock.
Ask your AI about Arcosa's increase (decrease) in advance billings.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude